Skip to main content

Table 1 Clinical characteristics of patients with MDD

From: Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder

Variables

Agea

year

42.4 ± 14.7

Body mass indexa

kg/m2

24.2 ± 3.1

Smoker / non smoker

n

13 / 41

HAM-Da

 

19.3 ± 7.0

GAFa

 

32.4 ± 7.6

Duration of illnessa

year

6.2 ± 7.9

No. depressive episodesa

 

1.7 ± 1.1

Antidepressant use

n (%)

39 (72.2)

 TCA

n (%)

1 (1.8)

 SSRI

n (%)

27 (50.0)

 SNRI

n (%)

7 (13.0)

 NaSSA

n (%)

4 (7.4)

Imipramine equivalencea

mg/day

110.7 ± 95.4

Benzodiazepine use

n (%)

17 (31.5)

Severity/course specifier at first medical examinationenzodiazepine use

 Mild

n (%)

14 (25.9)

 Moderate

n (%)

29 (53.7)

 Severe

n (%)

5 (9.2)

 With psychotic features

n (%)

3 (5.6)

 In partial remission

n (%)

3 (5.6)

  1. aValues are presented as mean ± standard deviation
  2. Abbreviations: HAM-D Hamilton Rating Scale for Depression, TCA Tricyclic antidepressants, SSRI Selective serotonin reuptake inhibitors, SNRI Serotonin-norepinephrine reuptake inhibitors, NaSSA Noradrenergic and specific serotonergic sntidepressant